HSCSW HeartSciences Inc. - Warrant
$0,04
Fiyat · Ağu 6, 2026
Temel veriler itibarıyla Tem 23, 2026
52 Haftlık Aralık
$0–$0
3% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
-0.0
ROE
-4239.9%
Net Kâr Marjı
-211666.5%
HSCSW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.04
Piyasa Değeri
—
P/E (TTM)
-0.0
EPS (TTM)
$-9.34
Gelir (TTM)
$4.3K
Temettü Verimi
—
ROE
-4239.9%
D/E Borç/Özsermaye
16.0
52 Haftlık Aralık
$0 – $0
HSCSW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$4.3K
2022-04-30
→
2026-04-30
Hisse Başına Kâr
$-9.34
2022-04-30
→
2025-04-30
Serbest Nakit Akışı
$-7M
2023-04-30
→
2026-04-30
Marjlar
-211666.5%
2023-04-30
→
2026-04-30
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
HSCSW
Akran Ortalaması
P/E (TTM)
-0.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
HSCSW
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
59.1%
—
Operating Margin (Faaliyet Kâr Marjı)
-194787.4%
—
Net Profit Margin (Net Kâr Marjı)
-211666.5%
—
ROE
-4239.9%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
HSCSW
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
16.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
HSCSW
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-0.71%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-5.7%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
HSCSW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | $4.3K | $4.3K | $18.6K | $5.2K | $14.4K | |
| Cost of Revenue | $1.8K | $1.9K | $6.1K | $2.8K | $7.9K | |
| Gross Profit | $2.6K | $2.5K | $12.5K | $2.4K | $6.5K | |
| R&D Expense | $3M | $4M | $3M | $2M | $3M | |
| SG&A Expense | $6M | $4M | $3M | $4M | $2M | |
| Operating Expenses | $8M | $8M | $6M | $6M | $5M | |
| Operating Income | $-8M | $-8M | $-6M | $-6M | $-5M | |
| Interest Expense | · | · | $354.1K | $243.2K | $371.6K | |
| Other Non-op | $24.0K | $87.8K | $-299.4K | $-241.3K | $-118.9K | |
| Income Tax | $0 | $0 | · | · | · | |
| Net Income | $-9M | $-9M | $-7M | $-6M | $-5M | |
| EPS (Basic) | $-3.48 | $-9.34 | $-18.74 | $-80.00 | $-1.45 | |
| EPS (Diluted) | · | $-9.34 | $-18.74 | $-80.00 | $-1.45 | |
| Shares (Basic) | 2,625,421 | 938,257 | 352,520 | 79,506 | 3,318,892 | |
| Shares (Diluted) | · | 938,257 | 352,520 | 79,506 | 3,318,892 | |
| EBITDA | $-8M | $-8M | $-6M | $-6M | · |
Bilanço 24
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $1M | $6M | $2M | $918.3K | |
| Receivables | · | $4.3K | · | · | $2.3K | |
| Inventory | $655.6K | $650.3K | $629.2K | $676.4K | $674.1K | |
| Prepaid Expense | · | $87.4K | $183.7K | $143.5K | $49.4K | |
| Other Current Assets | · | $40.4K | $40.4K | $40.4K | $40.4K | |
| Current Assets | · | $2M | $7M | $3M | $2M | |
| PP&E (Net) | $39.3K | $63.5K | $98.0K | $61.4K | $70.0K | |
| PP&E (Gross) | $604.5K | $600.9K | $597.8K | $533.3K | $515.0K | |
| Accum. Depreciation | $565.1K | $537.4K | $499.8K | $471.9K | $445.0K | |
| Intangibles | · | $2M | $2M | · | · | |
| Total Assets | · | $4M | $10M | $3M | $2M | |
| Accounts Payable | · | $318.7K | $448.2K | $631.4K | $694.7K | |
| Accrued Liabilities | · | $506.3K | $398.3K | $385.9K | $1M | |
| Short-term Debt | $4M | $3M | $500.0K | $500.0K | $2M | |
| Current Liabilities | · | $4M | $2M | $2M | $3M | |
| Capital Leases | $175.5K | $314.5K | $434.0K | $536.3K | · | |
| Total Liabilities | · | $4M | $2M | $3M | $8M | |
| Total Debt | $4M | $3M | $500.0K | $500.0K | · | |
| Common Stock | · | $1.1K | $677 | $101 | $3.3K | |
| Paid-in Capital | · | $76M | $75M | $61M | $48M | |
| Retained Earnings | $-85M | $-76M | $-67M | $-61M | $-54M | |
| Stockholders' Equity | $226.1K | $205.2K | $7M | $230.6K | $-6M | |
| Liabilities + Equity | · | $4M | $10M | $3M | $2M | |
| Shares Outstanding | · | 1,119,107 | 676,598 | 101,332 | 3,323,942 |
Nakit Akışı 10
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $249.9K | $405.0K | $248.3K | $68.4K | |
| Deferred Tax | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-7M | $-7M | $-6M | $-6M | $-4M | |
| CapEx | $3.6K | $3.2K | $64.5K | $18.3K | $1.9K | |
| Investing Cash Flow | $-44.5K | $-30.2K | $-125.3K | $-18.3K | $-1.9K | |
| Stock Issued | $172.8K | $1M | · | $5M | · | |
| Net Stock Activity | $172.8K | · | · | $5M | · | |
| Financing Cash Flow | $8M | $3M | $10M | $7M | $4M | |
| Net Change in Cash | $558.7K | $-5M | $4M | $742.2K | $194.8K | |
| Free Cash Flow | $-7M | $-7M | $-6M | $-6M | · |
Kârlılık 6
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Gross Margin | 59.1% | 56.8% | 67.3% | 45.7% | · | |
| Operating Margin | -194787.4% | -192013.1% | -33902.0% | -118698.3% | · | |
| Net Margin | -211666.5% | -201499.5% | -35511.9% | -123384.3% | · | |
| EBITDA Margin | -194787.4% | -192013.1% | -33902.0% | -118698.3% | · | |
| ROA | · | -127.7% | -103.3% | -236.4% | · | |
| ROE | -4239.9% | -880.1% | -82.8% | 46458.0% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Current Ratio | · | 0.6 | 4.2 | 1.5 | · | |
| Quick Ratio | · | 0.3 | 3.3 | 0.9 | · | |
| Debt / Equity | 16.0 | 12.4 | 0.1 | 2.2 | · | |
| Interest Coverage | · | · | -17.8 | -25.1 | · |
Verimlilik 3
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | 1.3 | · | · | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue YoY | -0.71% | -76.6% | 261.2% | -64.2% | · | |
| Revenue CAGR 3Y | -5.7% | -32.9% | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue TTM | $4.3K | $4.3K | $18.6K | $5.2K | $14.4K | |
| Net Income TTM | $-9M | $-9M | $-7M | $-6M | $-5M | |
| P/E | -0.0 | · | · | · | · | |
| Earnings Yield | -10297.5% | · | · | · | · |
Gelir Tablosu 15
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $2.4K | $1.9K | $4.3K | $0 | · | · | $0 | $14.7K | $3.9K | · | $0 | $1.9K | $0 | $3.2K | |
| Cost of Revenue | $0 | $0 | $1.0K | $760 | $1.9K | $0 | · | · | $0 | $4.6K | $1.5K | · | $0 | $760 | $0 | $2.0K | |
| Gross Profit | $0 | $0 | $1.4K | $1.1K | $2.5K | $0 | · | · | $0 | $10.1K | $2.4K | · | $0 | $1.2K | $0 | $1.2K | |
| R&D Expense | $476.2K | $638.6K | $727.0K | $997.2K | $929.1K | $1M | $1M | $1M | $1M | $509.5K | $757.3K | $565.6K | $534.4K | $643.3K | $849.0K | $434.2K | |
| SG&A Expense | $2M | $1M | $1M | $878.1K | $993.8K | $1M | $786.1K | $850.7K | $833.7K | $1M | $815.0K | $765.0K | $1M | $667.2K | $925.9K | $997.1K | |
| Operating Expenses | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $2M | $1M | |
| Operating Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $118.4K | $178.4K | $36.3K | $34.0K | $32.8K | $32.8K | $143.6K | |
| Other Non-op | $477.0K | $5.2K | $-277.4K | $-180.9K | $147.0K | $14.7K | $-97.9K | $24.0K | $33.6K | $-118.4K | $-178.4K | $-36.2K | $-33.7K | $-32.8K | $-31.6K | $-143.2K | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-2M | |
| EPS (Basic) | $-0.42 | $-0.63 | $-0.85 | $-1.58 | $-1.86 | $-2.57 | $-2.27 | $-2.64 | $13.42 | $-3.01 | $-15.92 | $-13.23 | $-79.34 | $-0.16 | $-0.22 | $-0.28 | |
| EPS (Diluted) | · | · | $-0.85 | $-1.58 | $-1.86 | $-2.57 | $-2.27 | $-2.64 | $13.42 | $-3.01 | $-15.92 | $-13.23 | $-79.34 | $-0.16 | $-0.22 | $-0.28 | |
| Shares (Basic) | -4,620,864 | 3,162,257 | 2,780,496 | 1,303,532 | -1,742,991 | 986,057 | 917,445 | 777,746 | -407,306 | 546,670 | 109,841 | 103,315 | -22,017,019 | 8,240,798 | 8,210,497 | 5,645,230 | |
| Shares (Diluted) | · | · | 2,780,496 | 1,303,532 | -1,742,991 | 986,057 | 917,445 | 777,746 | -407,306 | 546,670 | 109,841 | 103,315 | -22,017,019 | 8,240,798 | 8,210,497 | 5,645,230 | |
| EBITDA | · | · | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-1M | · | $-1M | $-2M | $-1M |
Bilanço 24
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $3M | $2M | $3M | $1M | $3M | $4M | $4M | $6M | $7M | $100.1K | $575.7K | $2M | $2M | $3M | $4M | |
| Receivables | · | $0 | · | · | $4.3K | · | · | · | · | $14.7K | $3.9K | · | · | · | · | · | |
| Inventory | $655.6K | $657.3K | $657.3K | $649.5K | $650.3K | $652.1K | $652.9K | $643.0K | $629.2K | $670.3K | $674.8K | $676.4K | $676.4K | $676.9K | $677.7K | $677.7K | |
| Prepaid Expense | · | $181.9K | $221.6K | $418.7K | $87.4K | $204.6K | $239.6K | $388.0K | $183.7K | $233.3K | $368.8K | $453.0K | $143.5K | $222.2K | $333.0K | $445.9K | |
| Other Current Assets | · | $40.4K | $258.0K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | $40.4K | |
| Current Assets | · | $5M | $4M | $4M | $2M | $4M | $6M | $6M | $7M | $9M | $2M | $2M | $3M | $3M | $4M | $5M | |
| PP&E (Net) | $39.3K | $46.1K | $53.0K | $56.4K | $63.5K | $71.1K | $77.1K | $86.1K | $98.0K | $58.4K | $53.3K | $59.0K | $61.4K | $60.7K | $64.1K | $70.9K | |
| PP&E (Gross) | $604.5K | $604.5K | $604.5K | $600.9K | $600.9K | $600.9K | $600.9K | $597.8K | $597.8K | $549.0K | $540.2K | $538.2K | $533.3K | $525.7K | $522.2K | $522.2K | |
| Accum. Depreciation | $565.1K | $558.4K | $551.5K | $544.5K | $537.4K | $529.8K | $523.8K | $511.6K | $499.8K | $490.6K | $486.8K | $479.2K | $471.9K | $465.0K | $458.2K | $451.4K | |
| Intangibles | · | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | · | · | |
| Total Assets | · | $8M | $6M | $6M | $4M | $6M | $8M | $8M | $10M | $11M | $2M | $3M | $3M | $3M | $5M | $6M | |
| Accounts Payable | · | $410.7K | $317.4K | $283.2K | $318.7K | $405.1K | $276.8K | $396.5K | $448.2K | $415.1K | $1M | $454.8K | $631.4K | $1M | $795.3K | $455.7K | |
| Accrued Liabilities | · | · | $311.2K | $599.3K | $506.3K | $315.9K | $369.7K | $331.1K | $398.3K | $584.4K | $772.7K | $631.0K | $385.9K | $644.6K | $890.7K | $505.5K | |
| Short-term Debt | $4M | $3M | $500.0K | $2M | $3M | $3M | $2M | $0 | $500.0K | $500.0K | $1M | $500.0K | $500.0K | $130.0K | $1M | $130.0K | |
| Current Liabilities | · | $4M | $2M | $3M | $4M | $4M | $3M | $1M | $2M | $2M | $4M | $2M | $2M | $2M | $3M | $2M | |
| Capital Leases | $175.5K | $211.9K | $247.3K | $281.6K | $314.5K | $345.8K | $376.2K | $405.7K | $434.0K | $460.9K | $486.9K | $512.1K | $536.3K | $549.2K | $549.2K | · | |
| Total Liabilities | · | $5M | $2M | $3M | $4M | $4M | $4M | $2M | $2M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | |
| Total Debt | · | · | $500.0K | $2M | · | $3M | $2M | $0 | · | $500.0K | $1M | $500.0K | · | $130.0K | $1M | $130.0K | |
| Common Stock | · | $3.2K | $3.1K | $2.3K | $1.1K | $1.0K | $948 | $907 | $677 | $63.6K | $11.2K | $10.7K | $101 | $8.3K | $8.2K | $8.2K | |
| Paid-in Capital | · | $85M | $85M | $81M | $76M | $76M | $76M | $75M | $75M | $74M | $62M | $62M | $61M | $59M | $59M | $59M | |
| Retained Earnings | $-85M | $-83M | $-81M | $-78M | $-76M | $-74M | $-71M | $-69M | $-67M | $-66M | $-64M | $-62M | $-61M | $-59M | $-58M | $-56M | |
| Stockholders' Equity | $226.1K | $3M | $4M | $3M | $205.2K | $2M | $4M | $6M | $7M | $9M | $-2M | $-519.7K | $230.6K | $-257.9K | $1M | $3M | |
| Liabilities + Equity | · | $8M | $6M | $6M | $4M | $6M | $8M | $8M | $10M | $11M | $2M | $3M | $3M | $3M | $5M | $6M | |
| Shares Outstanding | · | 3,184,207 | 3,071,135 | 2,281,054 | 1,119,107 | 1,032,321 | 947,821 | 906,416 | 676,598 | 63,611,630 | 11,213,438 | 10,670,980 | 101,332 | 8,349,859 | 8,210,503 | 8,174,375 |
Nakit Akışı 9
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $324.8K | $376.1K | $436.9K | $174.6K | $95.9K | $54.8K | $44.6K | $54.6K | $78.4K | $96.1K | $105.8K | $124.6K | $99.2K | $1.5K | $1.9K | $145.7K | |
| Operating Cash Flow | $-2M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-988.2K | $-1M | $-2M | $-1M | $-1M | $-2M | |
| CapEx | $0 | $-9.5K | · | · | $0 | $0 | · | · | $48.8K | $8.8K | $2.0K | $4.9K | $7.6K | $3.5K | $0 | $7.2K | |
| Investing Cash Flow | $0 | $-27.9K | $-15.8K | $-814 | $-7.8K | $-15.7K | $-5.8K | $-833 | $-69.2K | $-49.2K | $-2.0K | $-4.9K | $-7.6K | $-3.5K | $0 | $-7.2K | |
| Stock Issued | $0 | · | · | · | $171.3K | · | · | · | · | · | · | · | $0 | $0 | $0 | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Financing Cash Flow | $-63.7K | $3M | $2M | $4M | $100.0K | $180.2K | $2M | $551.7K | $377.1K | $9M | $514.6K | $324.4K | $2M | $-121.5K | $-116.4K | $5M | |
| Net Change in Cash | $-2M | $1M | $-841.1K | $2M | $-1M | $-1M | $-287.7K | $-1M | $-1M | $7M | $-475.5K | $-1M | $-270.5K | $-1M | $-1M | $3M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $-1M | · | · | · | $-2M |
Kârlılık 6
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 58.3% | 60.0% | · | · | · | · | · | 69.0% | 61.0% | · | · | 61.0% | · | 36.4% | |
| Operating Margin | · | · | -85713.2% | -98637.8% | · | · | · | · | · | -10376.8% | -40255.0% | · | · | -67143.7% | · | -44690.5% | |
| Net Margin | · | · | -97179.4% | -108157.6% | · | · | · | · | · | -11182.4% | -44830.2% | · | · | -68826.4% | · | -49165.7% | |
| EBITDA Margin | · | · | -85713.2% | -98637.8% | · | · | · | · | · | -10376.8% | -40255.0% | · | · | -67143.7% | · | -44690.5% | |
| ROA | · | · | -34.1% | -28.1% | · | -30.7% | -41.1% | -38.0% | · | -23.0% | -49.0% | -33.5% | · | -77.1% | -75.7% | -56.5% | |
| ROE | · | · | -57.3% | -45.3% | · | -48.7% | -176.0% | -75.8% | · | -39.2% | 616.7% | -115.5% | · | 1040.8% | -333.7% | -109.0% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 2.4 | 1.5 | · | 1.0 | 1.7 | 4.5 | · | 5.1 | 0.5 | 1.1 | · | 1.4 | 1.3 | 3.5 | |
| Quick Ratio | · | · | 1.2 | 0.9 | · | 0.7 | 1.2 | 3.2 | · | 4.2 | 0.0 | 0.3 | · | 1.0 | 1.0 | 2.8 | |
| Debt / Equity | · | 1.2 | 0.1 | 0.5 | · | 1.4 | 0.6 | 0.0 | · | 0.1 | -0.9 | -1.0 | · | -0.5 | 1.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -12.9 | -8.8 | -36.7 | · | -39.9 | -54.1 | -10.0 |
Verimlilik 3
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | 0.0 | 0.0 | · | · | 0.0 | · | 0.0 | |
| Inventory Turnover | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | 0.0 | 0.0 | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 0.0 | · | · | · | · | · | · | · | 2.0 | 2.0 | · | · | · | · | · |
Değerleme (TTM) 2
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $4.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | · | $-9M | $-9M | $-9M | · | $-8M | $-8M | $-7M | · | $-6M | $-6M | $-6M | · | $-6M | $-6M | $-4M |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2026-06-30 | 2026-04-30 | 2025-12-31 | 2025-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|
| Gelir | — | $4.3K | — | $4.3K | $18.6K |
| Brüt Kâr Marjı % | — | 59.1% | — | 56.8% | 67.3% |
| Faaliyet Kâr Marjı % | — | -194787.4% | — | -192013.1% | -33902.0% |
| Net Gelir | — | $-9M | — | $-9M | $-7M |
| Seyreltilmiş Hisse Başı Kâr | — | — | — | $-9.34 | $-18.74 |
Bilanço
| 2026-06-30 | 2026-04-30 | 2025-12-31 | 2025-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | 16.0 | — | 12.4 | 0.1 |
| Cari Oran | — | — | — | 0.6 | 4.2 |
| Cari Oran | — | — | — | 0.3 | 3.3 |
Nakit Akışı
| 2026-06-30 | 2026-04-30 | 2025-12-31 | 2025-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | $-7M | — | $-7M | $-6M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 4 dosya · $42K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 0 (0 önceki Ç'ye göre) | 0 (0 önceki Ç'ye göre) | 0 (-1 önceki Ç'ye göre) | 1 (0 önceki Ç'ye göre) | -5K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| CLEAR STREET LLC | $19.041 | 270.470 | 45,07% | Hisse senetleri |
| Clear Street Group Inc. | $13.593 | 270.770 | 32,17% | Hisse senetleri |
| CITADEL ADVISORS LLC | $9.562 | 187.495 | 22,63% | Hisse senetleri |
| UBS Group AG | $54 | 1.086 | 0,13% | Hisse senetleri |
Şirket yöneticileri 2 içeriden öğrenenler · 2 yöneticiler · 1 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Andrew Simpson | Chairman of the Board, President and Chief Executive Officer | 22 Haziran 2026 A | 499.382 | 0 | 0 | $0 |
| Danielle Watson | Chief Financial Officer | 07 Temmuz 2026 A | — | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Digital Currency Group, Inc., Fortitude Mining Holdings, Inc. | 18 Ağustos 2026 | 9,40% | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.